Epitopea
Montreal, CA · 3 known investors
Epitopea develops off-the-shelf cancer vaccines targeting aberrantly expressed tumor-specific antigens using its proprietary CryptoMap platform. The company serves patients with difficult-to-treat cancers across oncology.
Founders & leadership
CP
Claude Perreault
PT
Pierre Thibault